Paul Volberding

Last updated

Paul A. Volberding is an American physician who is best known for his pioneering work in treating people with HIV.

Contents

Work

Paul Volberding, 2012 Paul Volberding crop 2012 CHF HIV AIDS 061.jpg
Paul Volberding, 2012

In 1983, Volberding founded the first inpatient ward for persons with AIDS in the San Francisco General Hospital. [1] He worked on early clinical trials to evaluate antiretroviral therapy in HIV infection, and has served on the two major guidelines panels for antiretroviral therapy, addressing issues such as the optimal timing of treatment in early HIV infection when no symptoms are evident. [2]

In 2001 Volberding left the SF General Hospital to become chief medical officer at the San Francisco VA Medical Center, at which time he also became vice chairman of the department of medicine at the University of California, San Francisco (UCSF). [3] He went on to become the co-director of the Center for AIDS Research (CFAR) at UCSF and the Gladstone Institute of Virology and Immunology. In February 2012, he became the director of UCSF's AIDS Research Institute, and director of research for UCSF Institute for Global Health Sciences. [2]

Volberding is also the co-editor of the Journal of Acquired Immune Deficiency Syndromes [4] and the editor-in-chief of Current HIV/AIDS Reports . [5] He is the founding chair of the board of IAS-USA and sits on the board of Pangaea Global AIDS Foundation, advises at the Accordia Global Health Foundation, and is involved in many other activities to support research in HIV and global health.

Personal life

Volberding is married to Molly Cooke, an internist. [6]

Related Research Articles

University of California, San Francisco Public university in San Francisco, California

The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and it is dedicated entirely to health science. It is a major center of medical and biological research and teaching.

HIV/AIDS denialism False belief that HIV does not cause AIDS

HIV/AIDS denialism is the belief that human immunodeficiency virus (HIV) does not cause acquired immune deficiency syndrome (AIDS), despite conclusive evidence to the contrary. Some of its proponents reject the existence of HIV, while others accept that HIV exists but argue that it is a harmless passenger virus and not the cause of AIDS. Insofar as they acknowledge AIDS as a real disease, they attribute it to some combination of sexual behavior, recreational drugs, malnutrition, poor sanitation, haemophilia, or the effects of the medications used to treat HIV infection (antiretrovirals).

This is a timeline of AIDS, including AIDS cases before 1980.

amfAR

amfAR, the Foundation for AIDS Research, known until 2005 as the American Foundation for AIDS Research, is an international nonprofit organization dedicated to the support of AIDS research, HIV prevention, treatment education, and the advocacy of AIDS-related public policy.

HIV/AIDS Spectrum of conditions caused by HIV infection

Human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV), a retrovirus. Following initial infection an individual may not notice any symptoms, or may experience a brief period of influenza-like illness. Typically, this is followed by a prolonged incubation period with no symptoms. If the infection progresses, it interferes more with the immune system, increasing the risk of developing common infections such as tuberculosis, as well as other opportunistic infections, and tumors which are otherwise rare in people who have normal immune function. These late symptoms of infection are referred to as acquired immunodeficiency syndrome (AIDS). This stage is often also associated with unintended weight loss.

Douglas D. Richman is an American infectious diseases physician and medical virologist. Richman's work has focused on the HIV/AIDS pandemic, since its appearance in the early 1980s. His major contributions have been in the areas of treatment, drug resistance, and pathogenicity.

Merle Alden Sande was a leading American infectious-diseases expert whose early recognition of the looming public health crisis posed by AIDS led to the development of basic protocols for how to handle infected patients. He graduated from Washington State University and received his MD degree from the University of Washington, School of Medicine in Seattle.

Eric Goosby American public health official

Eric Goosby is an American public health official, currently serving as the UN Special Envoy on Tuberculosis. Goosby previously served as the United States Global AIDS Coordinator from 2009 until mid-November 2013. In the role, Goosby directed the U.S. strategy for addressing HIV around the world and led President Obama's implementation of the President's Emergency Plan for AIDS Relief (PEPFAR). Goosby was sworn in during June 2009 and resigned in November 2013, taking a position as a professor at UCSF, where he directs the Center for Global Health Delivery and Diplomacy, a collaboration between UCSF and the University of California, Berkeley.

Gladstone Institutes

Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.

Steffanie A. Strathdee Canadian epidemiologist

Steffanie A. Strathdee is the Associate Dean of Global Health Sciences, Harold Simon Professor at the University of California San Diego School of Medicine and Co-Director at the Center for Innovative Phage Applications and Therapeutics. She has been awarded more than US$64 million in federal research grants as a principal investigator. She is known for her work on HIV research and prevention programmes in Tijuana.

Julio S. G. Montaner, is an Argentine-Canadian physician, professor and researcher. He is the director of the British Columbia Centre for Excellence in HIV/AIDS, the chair in AIDS Research and head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia and the past-president of the International AIDS Society. He is also the director of the John Ruedy Immunodeficiency Clinic, and the Physician Program Director for HIV/AIDS PHC. He is known for his work on HAART, a role in the discovery of triple therapy as an effective treatment for HIV in the late 1990s, and a role in advocating the "Treatment as Prevention" Strategy in the mid-2000s, led by Myron Cohen of the HPTN 052 trial.

The Mississippi baby is a Mississippi girl who in 2013 was thought to have been cured of HIV. She had contracted HIV at birth from her HIV-positive mother. Thirty hours after the baby was born, she was treated with intense antiretroviral therapy. When the baby was about 18 months old, the mother did not bring the child in for scheduled examinations for the next five months. When the mother returned with the child, doctors expected to find high levels of HIV, but instead the HIV levels were undetectable. The Mississippi baby was thought to be the only other person, after the "Berlin patient," to have been cured of HIV. As a result, the National Institutes of Health planned to conduct a worldwide study on aggressive antiretroviral treatment of newborn infants of mothers with HIV infections. It was thought that aggressive antiretroviral therapy on newborn infants might be a cure for HIV. On July 10, 2014, however, it was reported that the child was found to be infected with HIV. Whether the worldwide study planned by the National Institutes of Health will be conducted remains uncertain.

Jay A. Levy, M.D. is an AIDS and cancer research physician. He is a professor of medicine with specialties in virology and immunology at the University of California, San Francisco (UCSF).

David Albert Cooper was an Australian HIV/AIDS researcher, immunologist, professor at the University of New South Wales, and the director of the Kirby Institute. He and Professor Ron Penny diagnosed the first case of HIV in Australia.

The San Francisco model of AIDS care began in 1983 in wards 86 and 5B of San Francisco General Hospital. The focus of this model was not only on the health of each patient with AIDS, but also on the well-being of each person. As AIDS was beginning to be treated as a significant epidemic, San Francisco General Hospital recognized the need to create new standards of care for a disease that had never before been experienced. Compassionate care has now become a priority worldwide and an expected standard in hospitals as there places a greater emphasis on the social, psychological, and economic aspects of treatment in addition to the medicine.

Robert T. Schooley American infectious disease physician

Robert "Chip" T. Schooley is an American infectious disease physician, who is the Vice Chair of Academic Affairs, Senior Director of International Initiatives, and Co-Director at the Center for Innovative Phage Applications and Therapeutics (IPATH), at the University of California San Diego School of Medicine. He is an expert in HIV and hepatitis C (HCV) infection and treatment, and in 2016, was the first physician to treat a patient in the United States with intravenous bacteriophage therapy for a systemic bacterial infection.

John S. Greenspan, is an academic dentist/scientist and university administrator. His degrees and diplomas include BSc, BDS, PhD, FRCPath, FDSRCS (Eng). He is the Director-Emeritus of the AIDS Research Institute at the University of California, San Francisco (UCSF). He was also the founding Director of the UCSF AIDS Specimen Bank (1982-2017) and of the UCSF Oral AIDS Center (1986–2005).

Diane Havlir US leader of HIV/AIDS work

Diane Havlir is an American physician who is a Professor of Medicine and Chief of the HIV/AIDS Division at the University of California, San Francisco. Her research considers novel therapeutic strategies to improve the lives of people with HIV and to support public health initiatives in East Africa. She was elected to the National Academy of Medicine in 2019.

Monica Gandhi American physician and academic researcher

Monica Gandhi is an American physician and professor. She teaches medicine at the University of California, San Francisco (UCSF) and is director of the UCSF Gladstone Center for AIDS Research and the medical director of the San Francisco General Hospital HIV Clinic, Ward 86. Her research considers HIV prevalence in women, as well as HIV treatment and prevention. She has been noted as a critic of some aspects of the COVID-19 lockdowns in the US.

Andrew Kambugu Ugandan physician

Andrew Ddungu Kambugu is a Ugandan physician who serves as The Sande-McKinnell Executive Director at Uganda Infectious Disease Institute and a Honorary Senior lecturer at Makerere University College of Sciences. He is also an Adjunct Associate Professor at the University of Minnesota. In July 2020, he was appointed to the United Nations 2021 Food System Scientific Group.

References

  1. Miller, Talea (6 June 2011). "Essay: Treating the Earliest Cases of AIDS". pbs.org. Retrieved 2 July 2011.
  2. 1 2 "Paul Volberding Takes Leading Roles with UCSF's ARI, Global Health Sciences". UCSF.edu News Center. University of California, San Francisco. 17 February 2012. Retrieved 7 March 2012.
  3. Perlman, David (25 January 2001). "Top AIDS Expert Quits S.F. General For VA Hospital". San Francisco Chronicle. Retrieved 30 May 2017.
  4. "Paul Volberding". thehivstoryproject.org. The HIV Story Project. Retrieved 7 March 2012.
  5. "Current HIV/AIDS Reports - incl. option to publish open access". springer.com. Retrieved 2017-07-31.
  6. Goodman, Ellen (February 26, 1988). "Doctors have right to know". The Sentinel. Retrieved October 6, 2021 via newspapers.com.